SCHEMBL3606399

SCHEMBL3606399

Cc1cc(C)c([N+](=O)[O-])c(C)c1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
CYP3A4 P08684 4/20 0.42
GRIN2D O15399 2/20 0.42
GRIN3B O60391 2/20 0.42
GRIN1 Q05586 2/20 0.42
GRIN2A Q12879 2/20 0.42
GRIN2B Q13224 2/20 0.42
GRIN2C Q14957 2/20 0.42
GRIN3A Q8TCU5 2/20 0.42
RECQL P46063 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
APEX1 P27695 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6156643 0.86 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL6579395 0.86 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL4918988 0.84 TDP1 (0.52) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL6671674 0.84 CYP1A2 (0.52) ALDH1A1TDP1CYP3A4RECQLMEN1
SCHEMBL27445177 0.84 TSHR (0.47) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL9793418 0.83 GRIN2D (0.46) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL14020980 0.80 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL6580997 0.79 ALDH1A1 (0.47) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B
SCHEMBL5320639 0.78 KDM4E (0.47) ALDH1A1TDP1CYP3A4MEN1KMT2A
SCHEMBL3219814 0.78 CYP3A4 (0.46) ALDH1A1TDP1CYP3A4GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371419-A PKMYT1 kinase inhibitors 杭州邦顺制药有限公司 2025-01-28 CN disclosed
CN-103508960-B Benzheterocyclic derivatives 江苏先声药业有限公司 2017-12-12 CN disclosed
US-20100022582-A1 Tetrahydroisoquinoline Compound and Medicinal Use Thereof KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2010-01-28 US disclosed
EP-1857444-A1 TETRAHYDROISOQUINOLINE COMPOUND AND MEDICINAL USE THEREOF Kyoto Pharmaceutical Industries, Ltd. (JP) 2007-11-21 EP disclosed
US-6433184-B1 HEAT AND CHEMICAL RESISTANCE KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2002-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022582-A1 Tetrahydroisoquinoline Compound and Medicinal Use Thereof ACAT1, ACAT2, LCAT ALDH1A1 88/4885TDP1 2400/4885CYP3A4 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.